Breaking News
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Pre-market Movers For April 18 (CHSI, SXCI, ABT, PFE, HAL, TXT, YHOO, IBM, INTC)

RELATED NEWS
Trade INTC now with 
4/18/2012 8:41 AM ET

Gainers:

Catalyst Health Solutions, Inc. (CHSI: Quote) is gaining 35 percent to $86.00. The company and SXC Health Solutions (SXCI: Quote, SXC.TO) would combine in a cash and stock transaction valued at about $4.4 billion. Catalyst shareholders will receive $28.00 cash and 0.6606 SXC shares for each Catalyst share, implying a purchase price of $81.02 per Catalyst share. SXCI is rising 16 percent to $92.92.

Abbott Laboratories (ABT: Quote) is rising 1 percent to $61.22. The company's first quarter earnings and sales grew from the previous year period and were above Wall Street view. In addition, the company raised its full-year 2012 ongoing earnings per share guidance.

Halliburton Co. (HAL: Quote) is up over 2 percent to $33.40. The company's profit increased from the previous year. consolidated revenue improved 30 percent from the year-ago quarter and were above consensus.

Textron Inc. (TXT: Quote) is up 1 percent to $28.01. The company's first quarter profit increased from the year-ago quarter and revenues rose 15.2 percent. Both earnings per share revenues were above analysts' estimates. Meanwhile, the company confirmed its guidance of 2012.

Yahoo! Inc. (YHOO: Quote) is up 3 percent to $15.47 as the company's first quarter profit and revenues increased from the previous year and also topped Wall Street view. The company guided second quarter revenues, excluding traffic acquisition costs, in-line with analysts' estimate.

Decliners:

Pfizer Inc. (PFE: Quote) is down 0.45 percent to $22.21. The company is reportedly close to selling its infant-nutrition business to Nestlé SA (NSRGY.PK) for at least $9 billion.

Cree, Inc. (CREE: Quote) is down over 5 percent to $30.16 as the company's third quarter profit plunged from the year-ago quarter. Non-GAAP earnings per share were below Wall Street view by a penny. Revenue rose 30 percent, but were below consensus. In addition, the company expects its fourth quarter results below analysts' expectations.

International Business Machines Corp. (IBM: Quote) is falling 2 percent to $203. The company's first quarter profit increased from the previous year and operating earnings per share were above Wall Street view. However, revenues fell short of analysts' estimate. Meanwhile, the company raised its full-year 2012 operating earnings guidance.

Intel Corp. (INTC: Quote) is down over 2 percent to $27.70. The company's first quarter profit declined from the year-ago quarter, but were above consensus. Net revenue increased from the prior year and also were above consensus.

Register
To receive FREE breaking news email alerts for Intel Corporation and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After showing a lack of direction throughout much of the session, stocks ended Monday's trading modestly lower. The slightly lower close on the day partly offset the strength that was seen in the markets last week. The major averages ended the day below the unchanged line but off their lows for the session. President Barack Obama reportedly plans to deliver a much-anticipated speech on Thursday outlining his administration's evolving counterterrorism policies. Multiple news sources cited a White House official as saying that Obama will address the use of drones and plans to close the detention facility at Guantanamo Bay in a speech at the National Defense University. A second union representing immigration enforcement officers has expressed opposition to the Senate version of comprehensive immigration reform legislation, arguing that the bill fails to address the "insurmountable bureaucracy" at the agency that oversees lawful immigration to the U.S.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.